MYOFINITY BIOSCIENCES INC
Woodbridge, United States · Founded 2018
- Headquarters
- Woodbridge, Connecticut
- Employees
- 1–10
- Founded
- 2018
- Business Model
- B2B
About
Myofinity Biosciences (operating as Myos Inc.) is a Connecticut-based biotech company developing protein therapeutics for muscular dystrophies including Duchenne and Becker muscular dystrophy. The company's lead program commercializes MyoTRIM, an engineered recombinant TRIM72/MG53 protein that enhances muscle cell membrane repair in skeletal and cardiac muscle. Research is conducted in collaboration with Yale University and Ohio State University under NIH STTR funding.
Summary
MYOFINITY BIOSCIENCES INC is a Biotech company based in Woodbridge, United States, founded in 2018.
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/myofinity-biosciences-inc"><img src="https://indexed.vc/api/badge/company/myofinity-biosciences-inc" alt="MYOFINITY BIOSCIENCES INC on Indexed.vc" width="260" height="76" /></a>